检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:罗小玲[1] 易晓英 彭小梅 Luo Xiaoling;Yi Xiaoying;Peng Xiaomei(The People's Hospital of Ji'an County,Ji'an,Jiangxi 343100)
出 处:《基层医学论坛》2018年第20期2756-2757,共2页The Medical Forum
基 金:吉安市科技计划任务
摘 要:目的探讨呋麻滴鼻液滴鼻在泪囊鼻腔吻合围手术期中的应用效果。方法选择我院2017年9月—2018年2月收治的泪囊鼻腔吻合术患者60例,将其随机分为对照组和观察组,每组30例。给予对照组患者术前3 d及术后2 h后呋麻滴鼻液滴鼻治疗,在对照组基础上,观察组术前1 h给予患者呋麻滴鼻液滴鼻治疗。比较2组患者术后24 h的流血、渗血以及术后48 h渗血、72 h渗血情况。结果观察组患者术后24 h鼻腔流血、渗血以及术后48 h鼻腔渗血发生率均低于对照组,差异具有统计学意义(P<0.05);2组患者术后72 h鼻腔渗血发生率比较,差异无统计学意义(P>0.05)。结论在泪囊鼻腔吻合术围手术期常规呋麻滴鼻液滴鼻治疗的基础上增加术前1 h呋麻滴鼻液滴鼻,可缓解患者术后鼻腔出血、渗血症状。Objective To investigate the application effect of ephedrine and furacilin nasal drops in dacryocystorhinostomy at perioperative period.Methods 60 patients with dacryocystorhinostomy admitted in our hospital from September 2017 to February 2018 were selected,and they were randomly divided into control group and observation group,30 cases in each group.Control group was given ephedrine and furacilin nasal drops before surgery for 3d and after surgery for 2h,while observation group was treated with ephedrine and furacilin nasal drops before surgery for 1h based on control group.The postoperative 24h bleeding and errhysis,postoperative 48h and 72h errhysis were compared between the two groups.Results The incidence of postoperative 24h nasal cavity bleeding and errhysis,postoperative 48h nasal cavity errhysis in observation group were lower than those in control group (P〈0.05).There was no statistical difference in the incidence of postoperative 72h nasal cavity errhysis between the two groups (P〉0.05).Conclusion Based on ephedrine and furacilin nasal drops in dacryocystorhinostomy at perioperative period,the application of preoperative 1h ephedrine and furacilin nasal drops can relieve postoperative nasal cavity bleeding and errhysis of patients.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.116.60.124